CASC3 and ovarian carcinoma: In addition, BTZ increased the IL-8 level in ovarian cancer cells[62] and in human monocytes and macrophages in vitro, thereby also inhibiting the expression of IL-6 and IL-1[63], which may explain why its expression was increased in our study.